UPDATED Mar 16, 2024
The market has not yet priced in the high-growth prospects for these companies, featuring low PEG ratio (less than 0.5), high future growth outlook and good value on the Snowflake.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
7172 | JP¥892.00 | -5.2% | -13.2% | JP¥27.0b | JP¥1,270.00 | PE11.4x | E58.1% | 3.6% | Diversified Financials | ||
3680 | JP¥323.00 | -5.3% | -5.3% | JP¥5.1b | JP¥2,559.28 | PE22.4x | E80.7% | n/a | Software | ||
7064 | JP¥2,418.00 | -5.5% | -33.1% | JP¥3.3b | n/a | PE10.9x | E25.5% | n/a | Software | ||
2395 | JP¥1,521.00 | -3.6% | -46.9% | JP¥63.3b | JP¥3,650.00 | PE11.5x | E23.2% | 3.3% | Pharmaceuticals & Biotech | ||
5480 | JP¥4,690.00 | -3.7% | 14.3% | JP¥67.9b | JP¥4,300.00 | PE4.5x | E48.4% | 4.9% | Materials | ||
8934 | JP¥1,695.00 | 2.1% | 38.3% | JP¥82.3b | n/a | PE7.5x | E20.3% | 3.5% | Real Estate Management and Development |